Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation
- 1 December 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 44 (6) , 1572-1580
Abstract
Five to 15% of patients with primary sclerosing cholangitis (PSC) develop cholangiocarcinoma (CC) with a median survival of 5 to 7 months, an outcome not significantly improved by liver transplantation. However, if CC is found incidentally during the procedure or in the explanted liver, 5-year survival rates of 35% are reported. A noninvasive method to detect CC small enough to allow for intended curative surgery is needed. Unfortunately, computed tomography (CT) and ultrasonography (US) have poor sensitivity for detection of CC in PSC; however, positron emission tomography (PET) using 2-[18F]fluoro-2-deoxy-D-glucose (FDG) differentiates well between CC and nonmalignant tissue. We examined whether PET findings are valid using a blinded study design comparing pretransplantation FDG-PET results with histology of explanted livers. Dynamic FDG-PET was performed in 24 consecutive patients with PSC within 2 weeks after listing for liver transplantation and with no evidence of malignancy on CT, magnetic resonance imaging, or ultrasonography. The PET Center staff was blinded to clinical findings, and surgeons and pathologists were blinded to the PET results. Three patients had CC that was correctly identified by PET. PET was negative in 1 patient with high-grade hilar duct dysplasia. In 20 patients without malignancies, PET was false positive in 1 patient with epitheloid granulomas in the liver. In conclusion , dynamic FDG-PET appears superior to conventional imaging techniques for both detection and exclusion of CC in advanced PSC. FDG-PET may be useful for screening for CC in the pretransplant evaluation of patients with PSC.Keywords
This publication has 22 references indexed in Scilit:
- Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancyJournal of Hepatology, 2004
- Biliary malignancies in primary sclerosing cholangitis: Timing for liver transplantationHepatology, 1996
- Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.Gut, 1996
- Primary sclerosing cholangitis: Liver transplantation or biliary surgerySurgery, 1995
- Risk factors in primary sclerosing cholangitisJournal of Hepatology, 1994
- Diagnostic Role of Serum CA 19-9 for Cholangiocarcinoma in Patients With Primary Sclerosing CholangitisMayo Clinic Proceedings, 1993
- Selection and Timing of Liver Transplantation in Primary Biliary Cirrhosis and Primary Sclerosing CholangitisHepatology, 1992
- Cholangiocarcinoma Complicating Primary Sclerosing CholangitisAnnals of Surgery, 1991
- Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake DataJournal of Cerebral Blood Flow & Metabolism, 1983
- Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: A re-examinationBrain Research Reviews, 1982